Aesthetic Practice Biologics Supplier in New Orleans, LA

How aesthetic practices evaluate a new supplier

A medspa, dermatology, or plastic surgery practice typically routes a new biologics vendor through its supervising physician or medical director before any product is stocked. The review usually covers donor screening at the time of donation, the processing window, and sterility testing results for the specific lot in question, not general marketing claims.

Precision Biologics makes lot-specific documentation, including a certificate of analysis and donor eligibility summary, available to verified accounts so this review can happen before an order is placed rather than after.

Account verification under physician supervision

Every account is tied to a supervising physician's verified NPI number. For a medspa with several injectors or aestheticians handling day-to-day work, this keeps ordering authority with the licensed physician responsible for the practice.

Receiving and storage for a New Orleans practice

Cryopreserved Wharton's jelly products arrive overnight on dry ice in validated containers and require -80 degree C storage once unpacked, so a practice needs a freezer and a logging step in place before its first delivery. Several exosome formats and the lyophilized Wharton's jelly product are shelf-stable, which reduces the storage commitment for a practice that would rather not maintain ultra-low-temperature freezer capacity.

Compliance checks before ordering

Exosome products are not FDA-approved and are generally regulated as biologic drugs; FDA has stated plainly that no exosome product currently has FDA approval. For Wharton's jelly products, whether a specific intended use satisfies the minimal-manipulation and homologous-use conditions of 21 CFR 1271.10 is a determination for the practice and its counsel, not something a distributor can certify. A practice should independently confirm its supervising physician's standing with the Louisiana medical board as part of its own review process.

Precision Biologics supports account setup with NPI-based verification and a physician-level documentation call covering certificates of analysis and lot records.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.